Sangamo Therapeutics, Inc. (SGMO) News
Filter SGMO News Items
SGMO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SGMO News From Around the Web
Below are the latest news stories about SANGAMO THERAPEUTICS INC that investors may wish to consider to help them evaluate SGMO as an investment opportunity.
Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite RiskyWe can readily understand why investors are attracted to unprofitable companies. For example, although... |
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call TranscriptSangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript November 2, 2023 Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised […] |
Sangamo to cut jobs again with planned business overhaulThe gene therapy company will move headquarters and reduce its workforce by 40%, while seeking partners for its Fabry and cell therapy research. |
Sangamo Therapeutics Inc (SGMO) Announces Q3 2023 Financial Results and Strategic UpdateCompany focuses on neurology-focused genomic medicine, announces restructuring and workforce reduction |
Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial ResultsBRISBANE, Calif., November 01, 2023--SANGAMO THERAPEUTICS ANNOUNCES STRATEGIC UPDATE AND REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS |
Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseSangamo (SGMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and WebcastBRISBANE, Calif., October 25, 2023--Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast |
Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)BRISBANE, Calif., October 24, 2023--Sangamo Therapeutics to Present Pre-Clinical Data Showcasing its Epigenetic Regulation for Neurology and CAR-Treg Research at ESGCT |
Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine SummitBRISBANE, Calif., September 20, 2023--Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine Summit |
Recent uptick might appease Sangamo Therapeutics, Inc. (NASDAQ:SGMO) institutional owners after losing 82% over the past yearKey Insights Significantly high institutional ownership implies Sangamo Therapeutics' stock price is sensitive to their... |